SCHEDULE: Commodore Capital Reports 0% Stake in Palisade Bio

Commodore Capital LP, Commodore Capital Master LP, Robert Egen Atkinson, and Michael Kramarz have jointly filed a Schedule 13G, reporting no beneficial ownership of Palisade Bio, Inc. common stock as of June 30, 2026.

Summary

• Commodore Capital LP, Commodore Capital Master LP, Robert Egen Atkinson, and Michael Kramarz (collectively, the "Filers") have filed an amended Schedule 13G.
• This filing indicates that as of June 30, 2026, the Filers collectively beneficially own 0.00 shares of Palisade Bio, Inc. common stock.
• This represents 0.0% of the class of securities.
• The filing is an amendment to a previous filing, and the Filers are certifying that the securities were not acquired or held for the purpose of influencing control of the issuer.

Sentiment

Score: 2

Explanation: StockSavvy.ai views this as a neutral filing, primarily indicating a change in reporting status rather than a significant shift in investment strategy or company performance.

Positives

• The filing confirms that the reporting persons do not hold a controlling stake or significant influence over Palisade Bio, Inc.

Negatives

• The reporting persons have zero beneficial ownership of Palisade Bio, Inc. common stock, indicating no current investment position.

Risks

• The filing does not contain any specific risks related to Palisade Bio, Inc. or the reporting persons' investment strategy.

Future Outlook

The filing does not contain any forward-looking statements or guidance regarding future investments or company performance.

Management Comments

• "By signing below I certify that, to the best of my knowledge and belief, the securities referred to above were not acquired and are not held for the purpose of or with the effect of changing or influencing the control of the issuer of the securities and were not acquired and are not held in connection with or as a participant in any transaction having that purpose or effect, other than activities solely in connection with a nomination under 240.14a-11."

Industry Context

StockSavvy.ai notes that Schedule 13G filings are typically made by institutional investors who acquire beneficial ownership of more than 5% of a class of a company's registered equity securities. This filing, reporting 0% ownership, suggests a divestment or a correction of a previous filing, rather than a new significant investment.

Stakeholder Impact

• Shareholders: The filing provides clarity on the ownership structure by confirming the absence of significant holdings by these specific entities, which may influence market perception of institutional interest.

Next Steps

• The reporting persons will continue to file amendments to Schedule 13G as required by SEC regulations.

Key Dates

Keywords

Schedule 13G, Commodore Capital, Palisade Bio, Beneficial Ownership, SEC Filing, Investment Management